This inventor holds 6 USPTO granted patents and 5 published patent applications. Top assignees: Dyno Therapeutics, Inc., Harvard College, University of Massachusetts. Active years: 2021-2026.
Company Filing History:
5 out of 5 
1 out of 3,071 
1 out of 1,625 
Years Active: 2021-2026
Title: The Innovative Journey of Samuel Wolock
Introduction
Samuel Wolock, an inventive mind hailing from Cambridge, MA, has made significant contributions to the field of biotechnology. With a total of four patents to his name, his work focuses on advanced methods for delivering therapeutic payloads, underscoring his role as a prominent figure among inventors in this domain.
Latest Patents
Among his notable inventions are patents related to capsid variants and methods of using these innovative polypeptides. His disclosures detail the potential of variant capsid polypeptides as vehicles for the effective delivery of therapeutic agents. This breakthrough has implications for drug delivery systems, potentially enhancing the efficacy of treatment modalities.
Career Highlights
Samuel Wolock has worked with esteemed organizations such as Dyno Therapeutics, Inc. and Harvard College. His tenure at these institutions has allowed him to leverage cutting-edge research and collaboration to foster innovation in biotechnology.
Collaborations
Throughout his career, Wolock has collaborated with notable individuals in the field, including Ina Chen and Jeff Gerold. These partnerships have contributed to his inventive endeavors, showcasing the collaborative spirit that drives progress in scientific research.
Conclusion
Samuel Wolock’s contributions to biotechnology through his innovative patents highlight the importance of creativity and collaboration in scientific advancements. His work not only exemplifies the potential of capsid variants in therapeutic applications but also sets a standard for future innovations in the industry.